Increasing prevalence of influenza drives the growth of the global point-of-care molecular diagnostics market
The global POC molecular diagnostics market is projected to reach USD 1440.2 million by 2023 from USD 725.5 million in 2018, at a CAGR of 14.7%. Growth in the POC molecular diagnostics market is driven by the increasing worldwide prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests. Growing R&D activities in molecular...